Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Cerebrotendinous xanthomatosis


Other Names for this Disease

  • Cerebral cholesterinosis
  • CTX
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Tests & Diagnosis

Newline Maker

Is genetic testing available for cerebrotendinous xanthomatosis?

Yes, testing of the CYP27A1 gene is available. The Genetic Testing Registry provides information on clinical and research tests available for this condition.
Last updated: 9/12/2013

How is cerebrotendinous xanthomatosis diagnosed?

Cerebrotendinous xanthomatosis is diagnosed by a combination of clinical features, cholestanol levels, and genetic testing. Individuals with cerebrotendinous xanthomatosis have high levels of cholestanol in their blood. Genetic testing of the CYP27A1 gene is also available and can detect mutations in about 98% of patients.[1]
Last updated: 9/12/2013

References
  1. Federico A, Dotti MT, Gallus GN. Cerebrotendinous Xanthomatosis. GeneReviews. August 1, 2013; http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ctx. Accessed 9/12/2013.


Other Names for this Disease
  • Cerebral cholesterinosis
  • CTX
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.